Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • slefevre
    Junior Member
    • Jun 2015
    • 4

    featureCounts output format error

    Hi

    I am trying to use the latest version of featureCounts (Subread package version 2.0.0) with the following command (based on Chothani, S. 2019. Current Protocols in Molecular Biology, 129, e108. doi: 10.1002/cpmb.108):

    featureCounts -T 5 -t CDS -g gene_id -O -J -R -G /cluster/home/sjannies/blast_databases/GCF_003368295.1_ASM336829v1_genomic.fna -a /cluster/home/sjannies/blast_databases/GCF_003368295.1_ASM336829v1_genomic.gtf -o rfp_mapped_to_goldfish_genome_featureCounts.txt /cluster/work/users/sjannies/rfp/star/bams/24hR50_rfp_goldfish_Aligned.sortedByCoord.out.bam

    I get the error: unknown output format: '-G'

    If I remove all extra options (-O -J -R -G ) featureCounts finish succesfully.


    Anyone have an idea what is wrong?

    Cheers
    Sjannie

    Below is head of gtf file:

    #gtf-version 2.2
    #!genome-build ASM336829v1
    #!genome-build-accession NCBI_Assembly:GCF_003368295.1
    #!annotation-source NCBI Carassius auratus Annotation Release 100
    NC_039243.1 Gnomon gene 5705 16574 . - . gene_id "LOC113109012"; db_xref "GeneID:113109012"; gbkey "Gene"; gene "LOC113109012"; gene_biotype "protein_coding";
    NC_039243.1 Gnomon exon 16363 16574 . - . gene_id "LOC113109012"; transcript_id "XM_026272525.1"; db_xref "GeneID:113109012"; gbkey "mRNA"; gene "LOC113109012"; model_evidence "Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 74 samples with support for all annotated introns"; product "OX-2 membrane glycoprotein-like, transcript variant X1"; exon_number "1";


    Output of command 'grep "CDS" /cluster/home/sjannies/blast_databases/GCF_003368295.1_ASM336829v1_genomic.gtf | head':

    NC_039243.1 Gnomon CDS 16363 16512 . - 0 gene_id "LOC113109012"; transcript_id "XM_026272525.1"; db_xref "GeneID:113109012"; gbkey "CDS"; gene "LOC113109012"; product "OX-2 membrane glycoprotein-like isoform X1"; protein_id "XP_026128310.1"; exon_number "1";
    NC_039243.1 Gnomon CDS 15265 15340 . - 0 gene_id "LOC113109012"; transcript_id "XM_026272525.1"; db_xref "GeneID:113109012"; gbkey "CDS"; gene "LOC113109012"; product "OX-2 membrane glycoprotein-like isoform X1"; protein_id "XP_026128310.1"; exon_number "2";


    Following is head of bam file:
    NB501273:265:HVMKCBGXC:3:22503:25876:14641 16 NC_039243.1 1360 255 16M1D14M * 0 0 TTAGATAAAACTTCTGCGCTTAACAGATCT EEAE/A/A//EEEEEEE6AEEEE/EAA/66 NH:i:1 HI:i:1 AS:i:25 nM:i:0 NM:i:1 MD:Z:16^C14 jM:B:c,-1 jI:B:i,-1
    NB501273:265:HVMKCBGXC:3:21606:21604:16716 272 NC_039243.1 6218 1 30M * 0 0 CTTCAGGCAGATACACAGACATACGAGCAG EEEEEEEEEEEEEEEEEEEEEEEEEAAAAA NH:i:4 HI:i:2 AS:i:29 nM:i:0 NM:i:0 MD:Z:30 jM:B:c,-1 jI:B:i,-1
  • abedkurdi
    Junior Member
    • Sep 2016
    • 2

    #2
    Hello slefevre,
    your problem here is with `-R` option. You have to specify which format to use: CORE, SAM or BAM.
    So it is failing because you are missing the format and it is considering `-G` as input for `-R`, that's why it is failing.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
      by SEQadmin2


      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

      The systematic characterization of the human proteome has
      ...
      07-20-2026, 11:48 AM
    • SEQadmin2
      Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
      by SEQadmin2



      Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
      ...
      07-09-2026, 11:10 AM
    • SEQadmin2
      Cancer Drug Resistance: The Lingering Barrier to Rising Survival
      by SEQadmin2



      Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

      There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
      07-08-2026, 05:17 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, Yesterday, 12:17 PM
    0 responses
    14 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-23-2026, 11:41 AM
    0 responses
    15 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-20-2026, 11:10 AM
    0 responses
    23 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-13-2026, 10:26 AM
    0 responses
    37 views
    0 reactions
    Last Post SEQadmin2  
    Working...